Published in J Inherit Metab Dis on February 17, 2010
Toxoplasma aldolase is required for metabolism but dispensable for host-cell invasion. Proc Natl Acad Sci U S A (2014) 1.08
Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in Drosophila. PLoS Genet (2013) 0.96
Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience (2015) 0.84
C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA. J Inherit Metab Dis (2013) 0.84
Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One (2014) 0.82
Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma. Mol Cancer (2015) 0.80
Hereditary fructose intolerance in Brazilian patients. Mol Genet Metab Rep (2015) 0.75
Liver glucose metabolism in humans. Biosci Rep (2016) 0.75
Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet (1990) 3.28
Intermediary metabolism of fructose. Am J Clin Nutr (1993) 2.92
Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem (1992) 2.35
Catalytic deficiency of human aldolase B in hereditary fructose intolerance caused by a common missense mutation. Cell (1988) 2.24
Molecular architecture of rabbit skeletal muscle aldolase at 2.7-A resolution. Proc Natl Acad Sci U S A (1987) 2.04
Multiple forms of fructose diphosphate aldolase in mammalian tissues. Proc Natl Acad Sci U S A (1966) 1.88
A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. Eur J Biochem (1989) 1.66
Distribution of fructose diphosphate aldolase variants in biological systems. Biochemistry (1969) 1.63
Diagnosis and treatment of galactosaemia. Br Med J (1954) 1.56
Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res (1996) 1.41
Hereditary fructose intolerance. J Med Genet (1998) 1.37
The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta (1981) 1.27
Molecular and catalytic properties of aldolase C. Biochemistry (1969) 1.24
Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase. J Biol Chem (2001) 1.16
Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet (1987) 1.12
Galactosemia: the good, the bad, and the unknown. J Cell Physiol (2006) 1.11
Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med (1978) 1.08
Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J (1973) 1.08
Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients. Am J Dis Child (1978) 1.07
Aldolase B and fructose intolerance. FASEB J (1994) 1.04
Molecular analysis of the fructose transporter gene (GLUT5) in isolated fructose malabsorption. J Clin Invest (1996) 1.04
The structure of human liver fructose-1,6-bisphosphate aldolase. Acta Crystallogr D Biol Crystallogr (2001) 0.98
Novel six-nucleotide deletion in the hepatic fructose-1,6-bisphosphate aldolase gene in a patient with hereditary fructose intolerance and enzyme structure-function implications. Eur J Hum Genet (1999) 0.97
Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr (1995) 0.97
Structure of the thermolabile mutant aldolase B, A149P: molecular basis of hereditary fructose intolerance. J Mol Biol (2005) 0.94
The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat (2005) 0.93
Disorders of fructose metabolism. Clin Endocrinol Metab (1976) 0.91
Fructosaemia: an inborn error of fructose metabolism. Arch Dis Child (1963) 0.90
Spatial clustering of isozyme-specific residues reveals unlikely determinants of isozyme specificity in fructose-1,6-bisphosphate aldolase. J Biol Chem (2003) 0.89
Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta (1978) 0.88
Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France--identification of eight new mutations. Mol Genet Metab (2008) 0.86
A young patient with unexplained acute hepatorenal dysfunction. Nephrol Dial Transplant (2003) 0.86
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS. Proteomics (2008) 0.85
Expression, purification, and characterization of natural mutants of human aldolase B. Role of quaternary structure in catalysis. J Biol Chem (2000) 0.85
Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. J Med Genet (1996) 0.85
Aldolase B mutations and prevalence of hereditary fructose intolerance in a Polish population. Mol Genet Metab (2006) 0.85
Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat (2004) 0.84
Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett (2002) 0.84
Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. A cause of growth retardation. N Engl J Med (1983) 0.83
Subcellular pathology of hereditary fructose intolerance. Am J Med (1968) 0.82
Thermodynamic analysis of the dissociation of the aldolase tetramer substituted at one or both of the subunit interfaces. Biol Chem (2003) 0.81
The temperature dependence of activity and structure for the most prevalent mutant aldolase B associated with hereditary fructose intolerance. Arch Biochem Biophys (2002) 0.81
A case of galactosaemia with the pathological and neuropathological findings. Arch Dis Child (1962) 0.80
Functional and molecular modelling studies of two hereditary fructose intolerance-causing mutations at arginine 303 in human liver aldolase. Biochem J (2000) 0.80
Hydrogen exchange demonstrates three domains in aldolase unfold sequentially. J Mol Biol (1999) 0.80
Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia. Pediatr Res (2007) 0.79
Alteration of substrate specificity by a naturally-occurring aldolase B mutation (Ala337-->Val) in fructose intolerance. Biochem J (1999) 0.78
Inborn errors of fructose metabolism. Am J Clin Nutr (1993) 0.78
An EST and STS-based YAC contig map of human chromosome 9q22.3. Genomics (1996) 0.77
Simple method for detection of mutations causing hereditary fructose intolerance. J Inherit Metab Dis (2002) 0.76
[Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance]. Anasth Intensivther Notfallmed (1987) 0.75
Secondary disorders of glycosylation in inborn errors of fructose metabolism. J Inherit Metab Dis (2009) 0.75
The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep (2008) 1.45
Molecular structure of human galactokinase: implications for type II galactosemia. J Biol Chem (2004) 1.24
The biology of habitat dominance; can microbes behave as weeds? Microb Biotechnol (2013) 1.11
Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinase. J Mol Biol (2004) 1.07
A universal measure of chaotropicity and kosmotropicity. Environ Microbiol (2012) 1.07
Molecular structure of Saccharomyces cerevisiae Gal1p, a bifunctional galactokinase and transcriptional inducer. J Biol Chem (2005) 1.06
Hydrophobic substances induce water stress in microbial cells. Microb Biotechnol (2010) 0.97
Multiplication of microbes below 0.690 water activity: implications for terrestrial and extraterrestrial life. Environ Microbiol (2014) 0.91
Development and implementation of split-GFP-based bimolecular fluorescence complementation (BiFC) assays in yeast. Biochem Soc Trans (2008) 0.90
The interaction of IQGAPs with calmodulin-like proteins. Biochem Soc Trans (2011) 0.87
Molecular structure of human galactose mutarotase. J Biol Chem (2004) 0.86
Functional domains of the human epididymal protease inhibitor, eppin. FEBS J (2008) 0.85
Structural and molecular biology of type I galactosemia: disease-associated mutations. IUBMB Life (2011) 0.85
Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia. Biochim Biophys Acta (2013) 0.84
Interactions of the 67 kDa laminin receptor and its precursor with laminin. Biosci Rep (2009) 0.84
Characterisation of two calmodulin-like proteins from the liver fluke, Fasciola hepatica. Biol Chem (2007) 0.82
The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sickness. Chem Biol Drug Des (2012) 0.82
In vivo and in vitro function of human UDP-galactose 4'-epimerase variants. Biochimie (2011) 0.82
Biochemical characterisation of triose phosphate isomerase from the liver fluke Fasciola hepatica. Biochimie (2013) 0.81
The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase. IUBMB Life (2011) 0.81
IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100B. Mol Cell Biochem (2008) 0.81
The role of the active site residues in human galactokinase: implications for the mechanisms of GHMP kinases. Bioorg Chem (2011) 0.81
Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity. J Med Chem (2007) 0.81
In silico identification and biochemical characterization of novel inhibitors of NQO1. Bioorg Med Chem Lett (2006) 0.81
FhCaBP3: a Fasciola hepatica calcium binding protein with EF-hand and dynein light chain domains. Biochimie (2012) 0.80
Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes. Mol Biochem Parasitol (2008) 0.80
A novel calmodulin-like protein from the liver fluke, Fasciola hepatica. Biochimie (2012) 0.80
A calcium-dependent interaction between calmodulin and the calponin homology domain of human IQGAP1. Mol Cell Biochem (2012) 0.80
Artemisinins act through at least two targets in a yeast model. FEMS Yeast Res (2010) 0.80
FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains. Parasitol Res (2012) 0.80
Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia. Biochim Biophys Acta (2012) 0.79
Effects of alcohols and compatible solutes on the activity of β-galactosidase. Appl Biochem Biotechnol (2012) 0.79
IQ-motif peptides as novel anti-microbial agents. Biochimie (2012) 0.79
Triose phosphate isomerase from the blood fluke Schistosoma mansoni: biochemical characterisation of a potential drug and vaccine target. FEBS Lett (2013) 0.79
Biochemical analysis of the interactions of IQGAP1 C-terminal domain with CDC42. World J Biol Chem (2012) 0.78
In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia. Gene (2013) 0.78
Detection and localisation of protein-protein interactions in Saccharomyces cerevisiae using a split-GFP method. Fungal Genet Biol (2008) 0.78
Characterization of the Saccharomyces cerevisiae galactose mutarotase/UDP-galactose 4-epimerase protein, Gal10p. FEMS Yeast Res (2007) 0.78
Interactions between the budding yeast IQGAP homologue Iqg1p and its targets revealed by a split-EGFP bimolecular fluorescence complementation assay. Cell Biol Int (2008) 0.78
Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug. Parasitol Res (2010) 0.77
Fragmentation of neutral amino acids and small peptides by intense, femtosecond laser pulses. J Am Soc Mass Spectrom (2013) 0.77
DNA damage by low-energy ions. Biochem Soc Trans (2009) 0.77
Differential expression of liver fluke β-tubulin isotypes at selected life cycle stages. Int J Parasitol (2013) 0.77
The Saccharomyces cerevisiae quinone oxidoreductase Lot6p: stability, inhibition and cooperativity. FEMS Yeast Res (2014) 0.76
Role of Arg228 in the phosphorylation of galactokinase: the mechanism of GHMP kinases by quantum mechanics/molecular mechanics studies. Biochemistry (2013) 0.76
Interaction of prothrombin with a phospholipid surface: evidence for a membrane-induced conformational change. Mol Cell Biochem (2010) 0.76
A plasma membrane Ca(2+)-ATPase (PMCA) from the liver fluke, Fasciola hepatica. Int J Parasitol (2012) 0.76
The contribution of key hydrophobic residues in ecotin to enzyme-inhibitor complex stability. J Enzyme Inhib Med Chem (2009) 0.75
Citrate synthase from the liver fluke Fasciola hepatica. Parasitol Res (2013) 0.75
Erratum: Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands. Sci Rep (2016) 0.75
Binding of serum albumin to the anthelmintic drugs albendazole, triclabendazole and their sulphoxides. Vet Parasitol (2010) 0.75
Increased promiscuity of human galactokinase following alteration of a single amino acid residue distant from the active site. Chembiochem (2011) 0.75
Plume characteristics and dynamics of UV and IR laser-desorbed oligonucleotides. Int J Biol Macromol (2012) 0.75
The GAL genetic switch: visualisation of the interacting proteins by split-EGFP bimolecular fluorescence complementation. J Basic Microbiol (2011) 0.75
A ligand predication tool based on modeling and reasoning with imprecise probabilistic knowledge. Comput Methods Programs Biomed (2009) 0.75
Split-EGFP screens for the detection and localisation of protein-protein interactions in living yeast cells. Methods Mol Biol (2010) 0.75
N-acetylgalactosamine kinase: a naturally promiscuous small molecule kinase. Appl Biochem Biotechnol (2011) 0.75
Development of a novel mass spectrometric technique for studying DNA damage. Biochem Soc Trans (2009) 0.75